# [11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes

> **NCT02967354** · NA · COMPLETED · sponsor: **Per-Ola Carlsson** · enrollment: 39 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **RADIATION:** Positron emission tomography with the tracer [11C]5-hydroxy-tryptophan

## Key facts

- **NCT ID:** NCT02967354
- **Lead sponsor:** Per-Ola Carlsson
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02967354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02967354, "[11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02967354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*